Speaker: Dr. Stephan Beisken, Head of Bioinformatics & Analytics, Ares Genetics GmbH, Wien
The rise of drug-resistant pathogens is an evolving problem impacting millions of patients around the world. Recent advancements in microbial genomics have progressed our ability to detect pathogens but lack the ability to diagnose antimicrobial resistance in a clinically actionable way. In this talk, Dr. Ares Genetics uses genome sequencing and AI-assisted bioinformatics solutions to enable infectious diseases testing and surveillance.
Ares Genetics is an award-winning Austria-based biotechnology company that offers services and tailored solutions on next-generation sequencing, bioinformatics and antibiotic resistance to partners in academia, public health and industry.
Ares Genetics and its parent-company Curetis are partners in the InfectoGnostics campus project "PREPLEX". A short introduction video of this collaborative project is available on YouTube.